Detalles de la búsqueda
1.
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy.
Oncol Rep
; 9(4): 887-96, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12066227
Resultados
1 -
1
de 1
1
Próxima >
>>